文献速递主动脉疾病

EVAS与烟囱EVAS治疗失败EVAR的初步经验

Endovascular Aneurysm Sealing (EVAS) and Chimney EVAS in the Treatment of Failed Endovascular Aneurysm Repairs.
PubMed 文献 · J Endovasc Ther · 2016-10-26

本研究评估Nellix EVAS系统治疗EVAR后并发症的技术成功率和临床结局。15例既往EVAR失败患者接受EVAS,其中10例联合烟囱技术(chEVAS)。技术成功率100%,所有内漏均成功封闭,中位随访8个月无再干预、动脉瘤相关死亡、移植物血栓形成、内漏或烟囱移植物闭塞。

要点

  • EVAS/chEVAS治疗失败EVAR技术成功率100%,可有效封闭内漏。
  • 中位随访8个月无再干预、动脉瘤相关死亡或移植物闭塞。
  • 该技术可作为其他方法不可行时的补救或替代治疗。

核心结论

  • EVAS/chEVAS治疗失败EVAR可行,可作为补救或替代治疗。

主要发现

  • 技术成功率100%,所有内漏成功封闭,无需额外干预。
  • 中位随访8个月(范围3-24),无再干预、动脉瘤相关死亡、移植物血栓形成、内漏或烟囱移植物闭塞。
  • 1例内袋突出无后遗症;1例老年破裂动脉瘤患者术后2个月死于多器官衰竭;1例肾动脉导丝损伤致肾切除。

关键数值与推荐

  • 失败EVAR类型:13例分叉型内移植物,1例分叉型加开窗 cuff,1例管型内移植物。
  • 内漏类型:Ia型10例,III型5例(IIIa型3例,IIIb型2例)。
  • 所有患者动脉瘤进展,中位直径7.85 cm(范围6.5-11)。
  • 8例急诊或紧急治疗(6例症状性动脉瘤,2例局限性破裂)。
  • 10例因近端锚定区不足联合烟囱技术(chEVAS)。

临床怎么用

  • 对于EVAR后失败且其他方法不可行时,可考虑EVAS/chEVAS作为补救或替代治疗。

局限性

  • 样本量小(15例),随访时间短(中位8个月),为初步经验。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To assess the technical success and clinical outcome of reinterventions using the Nellix Endovascular Aneurysm Sealing (EVAS) System to treat complications after endovascular aneurysm repair (EVAR). METHODS: Fifteen consecutive patients (mean age 79 years; 14 men) with prior EVAR were treated with EVAS between March 2014 and December 2015 at 2 institutions. The failed prior EVARs included 13 bifurcated endografts, 1 bifurcated graft plus fenestrated cuff, and 1 tube endograft. Endoleaks were the predominant indications: type Ia in 10 and type III in 5 (3 type IIIa and 2 type IIIb). All patients presented with progressive aortic aneurysms (median 7.85-cm diameter; range 6.5-11). Eight patients were treated on an urgent or emergency basis (6 symptomatic aneurysms and 2 contained ruptures). All patients underwent Nellix relining of the failed stent-graft; 10 had chimney (Ch) procedures in combination with EVAS (chEVAS) because the proximal landing zones were inadequate. RESULTS: Technical success was 100%. All endoleaks were successfully sealed, and no additional intervention was required. No further endoleak after EVAS or chEVAS was recorded. Endobag protrusion occurred in 1 case without sequelae. One elderly patient with ruptured aneurysm died from multiple organ failure 2 months postoperatively. One renal artery guidewire injury led to nephrectomy because of active bleeding. No reinterventions, aneurysm-related mortalities, graft thrombosis, endoleaks, or chimney graft occlusions were observed during a median follow-up of 8 months (range 3-24). CONCLUSION: The present preliminary experience demonstrates that the use of EVAS/chEVAS is feasible for treatment of failed EVAR. This technique may be used as bailout or an alternative treatment when other established methods are infeasible or not available.

来源:J Endovasc Ther,查看原文。版权归原作者所有。

引用

  1. Youssef M, Zerwes S, Jakob R, et al. Endovascular Aneurysm Sealing (EVAS) and Chimney EVAS in the Treatment of Failed Endovascular Aneurysm Repairs. J Endovasc Ther. 2016. PMID: 27798381. doi:10.1177/1526602816675622

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。